Bank Of New York Mellon Corp Sesen Bio, Inc. Transaction History

Bank Of New York Mellon Corp

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$0.49 - $0.61 $59,881 - $74,546	122,208 New	122,208 $74,000
Q2 2022 Aug 15, 2022	SELL	$0.38 - $0.89 $197,618 - $462,843	-520,049 Reduced 80.97%	122,208 $99,000
Q1 2022 May 11, 2022	BUY	$0.58 - $0.86 $28,498 - $42,256	49,135 Added 8.28%	642,257 $387,000
Q4 2021 Feb 11, 2022	BUY	$0.73 - $1.28 $30,864 - $54,118	42,280 Added 7.68%	593,122 $483,000
Q3 2021 Nov 12, 2021	BUY	$0.77 - $4.91 $63,330 - $403,837	82,248 Added 17.55%	550,842 $437,000
Q2 2021 Aug 11, 2021	BUY	$2.18 - $4.66 $822,468 - $1.76 Million	377,279 Added 413.16%	468,594 $2.16 Million
Q1 2021 May 13, 2021	SELL	$1.3 - $3.24 $54,342 - $135,438	-41,802 Reduced 31.4%	91,315 $237,000
Q4 2020 Feb 09, 2021	BUY	$1.01 - $1.77 $65,544 - $114,865	64,896 Added 95.13%	133,117 $179,000
Q2 2020 Aug 12, 2020	SELL	$0.52 - $0.87 $21,087 - $35,280	-40,552 Reduced 37.28%	68,221 $49,000
Q1 2020 May 06, 2020	SELL	$0.39 - $1.03 $224 - $593	-576 Reduced 0.53%	108,773 $60,000
Q2 2019 Aug 12, 2019	BUY	$0.95 - $2.46 $39,071 - $101,174	41,128 Added 60.29%	109,349 $164,000
Q1 2019 May 14, 2019	SELL	$0.69 - $1.47 $690 - $1,470	-1,000 Reduced 1.44%	68,221 $71,000
Q3 2018 Nov 09, 2018	SELL	$1.54 - $2.38 $9,549 - $14,758	-6,201 Reduced 8.22%	69,221 $0
Q2 2018 Aug 06, 2018	BUY	$1.04 - $3.29 $78,438 - $248,138	75,422 New	75,422 $147,000

Ticker SESN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 201,702,000
Market Cap $127M
Description
Sesen Bio, Inc., a late-stage clinical company, focuses on designing, engineering, developing, and commercializing targeted fusion protein therapeutics (TFPTs) for the treatment patients with cancer. Its lead product candidates include Vicineum, a locally-administered targeted fusion protein that is in Phase III clinical trials for the treatment...

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

Stay updated on Bank Of New York Mellon Corp with notifications on news.